论文部分内容阅读
目的探讨经尿道等离子电切术(PKRP)与经尿道前列腺汽化电切术(TUVP)治疗高危良性前列腺增生症(BPH)患者的疗效和安全性。方法选取2011年10月至2016年2月茂名石化医院收治的96例高危良性BPH患者作为研究对象,按随机数字表法将其分为观察组与对照组,各48例。观察组患者行PKRP治疗,对照组患者行TUVP治疗。比较两组患者手术时间等手术相关指标以及治疗前后最大尿流率(Q_(max))、残余尿量(RUV)、国际前列腺症状评分表(IPSS)评分等临床指标变化,并统计其术后并发症发生情况。结果观察组患者平均出血量明显少于对照组,术后膀胱持续冲洗时间、术后尿路刺激症状消失时间及住院时间均明显短于对照组,差异均有统计学意义(均P<0.05);治疗后,观察组患者的Qmax明显高于对照组,RUV、IPSS评分均明显少于对照组,差异均有统计学意义(均P<0.05);观察组患者术后并发症发生率明显低于对照组,差异有统计学意义(P<0.05)。结论 PKRP治疗高危良性BPH临床疗效显著,安全性高,并发症少。
Objective To investigate the efficacy and safety of transurethral plasmakinetic excision (PKRP) and transurethral vaporization of the prostate (TUVP) in the treatment of high-risk benign prostatic hyperplasia (BPH). Methods A total of 96 high-risk benign BPH patients who were admitted to Maoming Petrochemical Hospital from October 2011 to February 2016 were selected as research objects and divided into observation group and control group according to random number table method, 48 cases in each group. Patients in the observation group underwent PKRP treatment and patients in the control group underwent TUVP treatment. The changes of clinical indexes such as operation-related indexes and the maximum flow rate (Q max), residual urine volume (RUV) and IPSS score before and after treatment were compared between the two groups. The postoperative Complications of the situation. Results The average amount of bleeding in the observation group was significantly less than that in the control group. The duration of postoperative bladder irrigation, postoperative disappearance of urinary tract irritation and hospital stay were significantly shorter than those in the control group (all P <0.05) ; After treatment, the Qmax in the observation group was significantly higher than that in the control group, and the scores of RUV and IPSS were significantly less than those in the control group (all P <0.05); the incidence of postoperative complications in the observation group was significantly lower In the control group, the difference was statistically significant (P <0.05). Conclusion The clinical efficacy of PKRP in the treatment of high-risk benign BPH is significant, with high safety and few complications.